To test this hypothesis, we decided to examine our innovative idea with miR-125a and miR-205, and to determine whether co-expression of the two miRNAs will exert functional cooperation to inhibit erbB3 expression in HER2-overexpressing breast cancer cells. Here, ERBB2 is linked to breast cancer.